Metraipolis › archive › dc_47df461d2584
Evaluating the Utility and Implementation Barriers of a Liquid Biopsy Biomarker Test Early in the Lung Cancer Diagnostic Pathway to Improve Timeliness of… — Europe PMC PMID:41590362
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41590362
- DOI
- 10.3390/curroncol33010042
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T20:14:14.777Z
- SHA-256 of the archived text
23c6face38bafc984d37a345ef800da35e12701a766b5db3819f3cd813bf9cc3- Stable URL of this page
https://metraipolis.com/documento/dc_47df461d2584
How to cite
Evaluating the Utility and Implementation Barriers of a Liquid Biopsy Biomarker Test Early in the Lung Cancer Diagnostic Pathway to Improve Timeliness of… — Europe PMC PMID:41590362 — Europe PMC (en), https://europepmc.org/article/MED/41590362 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_47df461d2584 (Metraipolis archive dc_47df461d2584, sha256 23c6face38bafc984d37a345ef800da35e12701a766b5db3819f3cd813bf9cc3)
BibTeX
@misc{dc47df461d2584,
title = {Evaluating the Utility and Implementation Barriers of a Liquid Biopsy Biomarker Test Early in the Lung Cancer Diagnostic Pathway to Improve Timeliness of… — Europe PMC PMID:41590362},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41590362},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_47df461d2584; sha256 23c6face38bafc984d37a345ef800da35e12701a766b5db3819f3cd813bf9cc3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41590362. Agents can read the archived copy with the MCP tool read_document.